The administration of antihistamines in the immediate pre-operative period is generally avoided due to a constellation of potential adverse effects. These medications, while effective in mitigating allergic reactions, can interact negatively with anesthesia and other drugs commonly used during surgical procedures. For instance, certain antihistamines possess sedative properties that, when combined with anesthetics, may lead to excessive drowsiness or respiratory depression.
The practice of withholding antihistamines before surgery stems from a focus on patient safety and optimizing the surgical environment. Minimizing drug interactions is paramount to ensure predictable and controlled anesthesia. Historically, the potential for these interactions was not always fully appreciated, leading to instances of prolonged recovery times and other complications. Modern protocols emphasize thorough medication reconciliation and a careful assessment of each patient’s individual risk factors before surgery.
This cautious approach necessitates a nuanced understanding of antihistamine pharmacology and its potential impact on perioperative care. Subsequent sections will explore specific mechanisms of action, alternative management strategies for allergic conditions, and detailed guidelines concerning pre-operative medication management.
1. Sedation
The sedative properties inherent in many antihistamines represent a significant concern in the context of pre-operative medication management. When administered prior to surgery, these medications can potentiate the effects of anesthetic agents, leading to excessive drowsiness and delayed emergence from anesthesia. This heightened level of sedation complicates post-operative monitoring and may mask early signs of complications, such as respiratory distress or altered neurological function. For example, a patient who received an antihistamine with notable sedative effects prior to surgery may exhibit a prolonged period of unresponsiveness post-operatively, making it difficult to assess their neurological status and identify potential adverse events promptly.
The increased sedation resulting from pre-operative antihistamine use can also prolong the length of stay in the post-anesthesia care unit (PACU). Patients who are excessively sedated require more intensive monitoring and support, delaying their transfer to a general ward. This extended recovery period not only increases healthcare costs but also exposes patients to a higher risk of hospital-acquired infections and other complications. Moreover, the delayed return to baseline cognitive function can impede early mobilization and rehabilitation efforts, further prolonging the overall recovery process.
In conclusion, the risk of excessive sedation is a primary factor contributing to the practice of withholding antihistamines before surgery. The potential for prolonged recovery, masked complications, and increased healthcare costs necessitates a careful evaluation of the risks and benefits of antihistamine use in the pre-operative setting. Alternative strategies for managing allergic reactions or other conditions requiring antihistamine therapy should be considered in consultation with the anesthesiology team to ensure patient safety and optimize surgical outcomes.
2. Drug Interactions
The potential for significant drug interactions is a crucial determinant in the practice of withholding antihistamines prior to surgical interventions. These interactions can manifest in a variety of ways, often exacerbating the effects of anesthetic agents or other medications administered during the perioperative period. For instance, certain antihistamines can potentiate the sedative effects of opioids and benzodiazepines, increasing the risk of respiratory depression and prolonged recovery. This synergistic effect necessitates careful consideration of all medications a patient is taking to mitigate potential adverse outcomes. The administration of promethazine, an antihistamine with antiemetic properties, alongside certain anesthetics, can increase the risk of extrapyramidal symptoms and other neurological complications, highlighting the importance of avoiding unnecessary polypharmacy.
Understanding the pharmacokinetic and pharmacodynamic interactions between antihistamines and other perioperative medications is essential for safe patient management. Antihistamines can compete with other drugs for binding sites on plasma proteins, altering their distribution and metabolism. This can lead to unpredictable drug levels and increased toxicity. Moreover, some antihistamines possess anticholinergic properties, which can interact with anticholinergic anesthetics or other medications, potentially causing urinary retention, blurred vision, and increased intraocular pressure. This is particularly relevant in patients with pre-existing conditions such as glaucoma or benign prostatic hyperplasia, where the additive anticholinergic effects can exacerbate their symptoms. Careful medication reconciliation and a thorough review of a patient’s medical history are critical steps in identifying potential drug interactions before surgery.
In summary, the risk of drug interactions is a primary justification for avoiding pre-operative antihistamine administration. The potential for synergistic sedation, altered drug metabolism, and additive anticholinergic effects can compromise patient safety and complicate surgical procedures. Strategies for managing allergic conditions or other indications for antihistamines should be carefully reviewed and alternative medications or approaches considered in consultation with the anesthesiology team. Prioritizing patient safety requires a comprehensive understanding of potential drug interactions and a commitment to evidence-based medication management practices.
3. Respiratory Depression
The association between antihistamine administration and an increased risk of respiratory depression forms a significant component of the rationale for avoiding their use before surgery. Certain antihistamines, particularly first-generation agents, possess sedative properties that can synergize with the respiratory depressant effects of anesthetic agents and opioid analgesics commonly employed during surgical procedures. This combined effect can lead to a reduction in respiratory drive, decreased tidal volume, and ultimately, hypoxemia. For example, a patient receiving diphenhydramine pre-operatively may exhibit a blunted response to hypercapnia, reducing the body’s natural drive to breathe and increasing the susceptibility to respiratory complications under anesthesia.
The mechanisms underlying this increased risk are multifactorial. Sedative antihistamines can directly depress the central nervous system, diminishing the responsiveness of respiratory centers in the brainstem. Additionally, some antihistamines exhibit anticholinergic effects, which can thicken respiratory secretions and impair mucociliary clearance, further compromising respiratory function. Patients with pre-existing respiratory conditions, such as chronic obstructive pulmonary disease (COPD) or asthma, are particularly vulnerable to these effects. In such cases, the combination of pre-operative antihistamines and anesthetic agents can precipitate acute respiratory failure, necessitating mechanical ventilation and intensive care. Consequently, vigilant pre-operative assessment and the avoidance of unnecessary sedatives, including antihistamines, are critical in minimizing the risk of respiratory complications.
In summary, the potential for additive respiratory depression resulting from pre-operative antihistamine administration represents a serious clinical concern. The synergistic effects with anesthetic agents, coupled with potential anticholinergic side effects and the vulnerability of patients with pre-existing respiratory conditions, underscore the importance of careful medication management in the surgical setting. The avoidance of routine antihistamine use before surgery, coupled with individualized risk assessment and the judicious use of alternative therapies, is paramount in safeguarding patient respiratory function and ensuring optimal surgical outcomes.
4. Prolonged Recovery
The phenomenon of prolonged recovery following surgical procedures is significantly influenced by pre-operative medication management, with antihistamine administration representing a notable consideration. The avoidance of antihistamines in the pre-operative period is often predicated on mitigating factors that can impede or delay a patient’s return to baseline function.
-
Delayed Awakening from Anesthesia
Many antihistamines, particularly first-generation agents, possess sedative properties that can interact synergistically with anesthetic drugs. This potentiation of sedative effects can delay a patient’s awakening from anesthesia, extending the time spent in the post-anesthesia care unit (PACU). For example, a patient given diphenhydramine before surgery may exhibit a slower return to cognitive function, requiring more intensive monitoring and delaying transfer to a regular ward. This necessitates additional resources and increases the overall healthcare costs associated with the procedure.
-
Cognitive Impairment
Antihistamines, even those with supposedly less sedative effects, can contribute to post-operative cognitive impairment. This manifests as difficulties with memory, attention, and executive function, hindering a patient’s ability to follow instructions, participate in rehabilitation, and manage their post-operative care effectively. For example, a patient struggling with cognitive impairment may have difficulty understanding medication schedules or wound care instructions, increasing the risk of complications and re-hospitalization. The lingering effects of antihistamines on cognitive function can thus prolong the overall recovery process.
-
Increased Risk of Post-Operative Delirium
Especially in elderly patients, pre-operative antihistamine use has been linked to an increased risk of post-operative delirium. Delirium is a state of acute confusion and disorientation that can significantly prolong hospital stays, increase morbidity, and negatively impact long-term cognitive outcomes. The anticholinergic properties of certain antihistamines are believed to contribute to this risk. A patient experiencing delirium may require intensive nursing care, pharmacological interventions, and potentially prolonged rehabilitation, substantially extending their recovery period and increasing the burden on healthcare resources.
-
Impaired Motor Function and Balance
Antihistamines can impact motor function and balance, particularly in patients who are already frail or have pre-existing mobility issues. This can increase the risk of falls and injuries during the post-operative period, further complicating and prolonging recovery. A patient experiencing impaired balance due to antihistamine effects may require assistance with ambulation, potentially delaying their return to independent living and increasing the need for physical therapy. By avoiding pre-operative antihistamine use, healthcare providers aim to minimize these potential impairments and facilitate a smoother, more efficient recovery process.
The avoidance of pre-operative antihistamine administration is therefore a strategic measure intended to minimize factors that can contribute to prolonged recovery. The potential for delayed awakening, cognitive impairment, increased risk of delirium, and impaired motor function all underscore the importance of careful medication management in the surgical setting. By prioritizing patient safety and minimizing unnecessary drug exposure, healthcare providers strive to optimize recovery trajectories and improve overall surgical outcomes.
5. Anesthesia Complications
The use of antihistamines preoperatively can significantly influence the risk profile associated with anesthesia administration. Their interactions with anesthetic agents can precipitate a variety of complications, necessitating careful consideration of medication management strategies in the perioperative period.
-
Potentiation of Sedative Effects
Many antihistamines, especially first-generation agents, possess intrinsic sedative properties. When combined with anesthetics, which also depress the central nervous system, a synergistic effect can occur, leading to excessive sedation. This potentiation can result in prolonged recovery times, increased risk of respiratory depression, and delayed awakening from anesthesia. For example, combining diphenhydramine with a benzodiazepine used for pre-operative anxiety can significantly increase the likelihood of post-operative respiratory insufficiency, requiring prolonged mechanical ventilation.
-
Increased Risk of Hypotension
Certain antihistamines exhibit anticholinergic properties that can impair cardiovascular function. These medications can interfere with the autonomic nervous system’s control of blood pressure, leading to hypotension, particularly in conjunction with anesthetic agents that also lower blood pressure. In patients with pre-existing cardiovascular disease or those undergoing major surgical procedures, this can compromise tissue perfusion and increase the risk of end-organ damage. An example is the use of promethazine which can exacerbate hypotension during spinal anesthesia, requiring vasopressor support.
-
Drug Interactions and Metabolism
Antihistamines can interact with various anesthetic drugs, altering their metabolism and potentially increasing their toxicity. Some antihistamines can inhibit cytochrome P450 enzymes, which are crucial for the metabolism of many anesthetic agents. This inhibition can lead to elevated levels of anesthetic drugs in the bloodstream, increasing the risk of adverse effects such as arrhythmias, prolonged sedation, and hepatotoxicity. The concurrent use of chlorpheniramine and certain volatile anesthetics can, for example, increase the risk of cardiac arrhythmias due to the altered metabolism of the anesthetic agent.
-
Exacerbation of Anticholinergic Effects
Many anesthetic agents and adjunct medications possess anticholinergic properties. When combined with antihistamines that also have anticholinergic effects, an additive effect can occur, leading to a constellation of symptoms, including dry mouth, blurred vision, urinary retention, and constipation. In elderly patients, this cumulative anticholinergic burden can increase the risk of post-operative delirium, a serious complication characterized by confusion, disorientation, and cognitive impairment. The use of atropine for bradycardia in combination with pre-operative hydroxyzine can, for instance, precipitate acute urinary retention, especially in men with benign prostatic hyperplasia.
These potential anesthesia complications underscore the importance of avoiding antihistamine administration before surgery. A thorough evaluation of a patient’s medication history, consideration of potential drug interactions, and a careful assessment of individual risk factors are essential for minimizing the risk of adverse events and ensuring patient safety. When antihistamines are deemed necessary, alternative agents with minimal sedative and anticholinergic effects should be considered, and the anesthesia team should be fully informed of their use.
6. Cardiovascular Effects
The rationale for avoiding pre-operative antihistamine administration is significantly reinforced by the potential for adverse cardiovascular effects. Certain antihistamines, particularly first-generation agents, possess the capacity to disrupt normal cardiovascular function through a variety of mechanisms. The most prominent of these is the prolongation of the QT interval on electrocardiograms. This prolongation increases the risk of potentially fatal ventricular arrhythmias, such as Torsades de Pointes, especially in patients with pre-existing cardiac conditions or those concurrently taking other QT-prolonging medications. For instance, a patient with a history of long QT syndrome or heart failure, already at elevated risk for arrhythmias, faces a further augmented risk if administered antihistamines pre-operatively. This risk necessitates careful consideration of the patient’s cardiac history and a thorough review of their medication profile before surgery. The implication is that antihistamines can upset the delicate balance of cardiac electrophysiology, making the heart more susceptible to dangerous rhythm disturbances under the physiological stress of surgery and anesthesia.
Furthermore, some antihistamines exhibit anticholinergic properties, leading to increased heart rate (tachycardia) and potentially elevated blood pressure. While these effects may be transient and clinically insignificant in healthy individuals, they can be detrimental in patients with coronary artery disease or hypertension. Tachycardia increases myocardial oxygen demand, potentially leading to angina or myocardial ischemia in patients with pre-existing coronary artery stenosis. Elevated blood pressure, even transiently, can increase the risk of stroke or other cardiovascular events, particularly in patients with poorly controlled hypertension or a history of cerebrovascular disease. Consequently, the cardiovascular effects of antihistamines must be carefully weighed against the potential benefits, especially in patients with pre-existing cardiovascular vulnerabilities. A specific example would be a patient with uncontrolled hypertension undergoing a high-risk surgery; the added cardiovascular stress from an antihistamine could precipitate a hypertensive crisis.
In summary, the potential for adverse cardiovascular effects, ranging from QT prolongation and arrhythmias to tachycardia and hypertension, forms a critical component of the decision-making process regarding pre-operative antihistamine administration. The risks are particularly pronounced in patients with pre-existing cardiac conditions or those taking other medications that affect cardiovascular function. Therefore, a thorough pre-operative cardiovascular assessment and a careful review of medication profiles are essential to mitigate these risks and ensure patient safety. The avoidance of routine antihistamine use before surgery, coupled with individualized risk assessment and the judicious use of alternative therapies when necessary, remains the cornerstone of best practice in perioperative care.
7. Altered Mental Status
The potential for altered mental status following surgical procedures is a significant concern influencing the decision to avoid antihistamine administration pre-operatively. This consideration stems from the inherent sedative and anticholinergic properties of many antihistamines, which can interact synergistically with anesthesia and other medications, leading to cognitive dysfunction and impaired awareness.
-
Cognitive Impairment and Confusion
Antihistamines, particularly first-generation agents like diphenhydramine and promethazine, can readily cross the blood-brain barrier, exerting sedative effects on the central nervous system. This can result in cognitive impairment, characterized by difficulties with attention, memory, and executive function. Patients may experience confusion, disorientation, and difficulty processing information, hindering their ability to follow instructions, participate in rehabilitation, and communicate their needs effectively. For example, a patient who received an antihistamine pre-operatively might struggle to recall post-operative instructions regarding medication administration or wound care, increasing the risk of complications and re-hospitalization. This impairment is especially pronounced in elderly patients, who are more susceptible to the cognitive side effects of antihistamines due to age-related changes in brain function and drug metabolism.
-
Delirium
Antihistamines, due to their anticholinergic properties, contribute to the risk of post-operative delirium, a serious complication characterized by acute confusion, fluctuating levels of consciousness, and disturbances in attention, perception, and thought. Delirium can significantly prolong hospital stays, increase morbidity and mortality, and negatively impact long-term cognitive outcomes. The anticholinergic effects of antihistamines disrupt the balance of neurotransmitters in the brain, particularly acetylcholine, leading to impaired cognitive function and behavioral disturbances. Patients experiencing delirium may exhibit agitation, hallucinations, delusions, and disorganized thinking, requiring intensive nursing care, pharmacological interventions, and potentially prolonged rehabilitation. For instance, an elderly patient who receives an antihistamine for pre-operative anxiety may develop delirium in the post-operative period, necessitating a longer hospital stay and increasing the risk of long-term cognitive decline. Avoiding antihistamines can reduce anticholinergic burden and lower the risk of delirium.
-
Sedation and Delayed Awakening
The sedative properties of many antihistamines can potentiate the effects of anesthetic agents, leading to excessive sedation and delayed awakening from anesthesia. This can prolong the time spent in the post-anesthesia care unit (PACU) and delay the patient’s return to baseline cognitive function. Patients who are excessively sedated may exhibit a reduced level of responsiveness, making it difficult to assess their neurological status and identify potential complications promptly. For example, a patient who received an antihistamine pre-operatively may remain drowsy and disoriented for an extended period after surgery, hindering their ability to communicate pain levels or other symptoms. This prolonged sedation can also impede early mobilization and rehabilitation efforts, further prolonging the overall recovery process. Minimizing pre-operative antihistamine use allows for a more predictable and timely emergence from anesthesia.
-
Impact on Neurological Assessment
Pre-operative antihistamine use can complicate post-operative neurological assessments. The sedative and anticholinergic effects of these medications can mask or mimic neurological deficits, making it difficult to differentiate between drug-induced cognitive impairment and underlying neurological conditions. This can delay accurate diagnosis and appropriate management of neurological complications, such as stroke or traumatic brain injury. For example, a patient who experiences a post-operative stroke may exhibit symptoms that are initially attributed to the effects of pre-operative antihistamines, leading to a delay in the administration of time-sensitive treatments. Consequently, avoiding antihistamines when possible allows for a clearer and more reliable neurological evaluation in the post-operative period, facilitating timely intervention and improving patient outcomes.
The multifaceted impact of altered mental status underscores the importance of carefully considering antihistamine use before surgery. By recognizing the potential for cognitive impairment, delirium, delayed awakening, and compromised neurological assessment, healthcare providers can make informed decisions to minimize the risk of adverse outcomes and optimize patient safety. A comprehensive pre-operative assessment, coupled with the judicious use of alternative therapies when necessary, is essential for mitigating the cognitive risks associated with antihistamines and ensuring a smoother, more predictable recovery.
8. Unpredictable Response
The rationale for avoiding pre-operative antihistamine administration is significantly amplified by the potential for unpredictable responses. Patients exhibit considerable variability in their reactions to these medications, making it difficult to predict the magnitude and nature of their effects. This unpredictability is particularly problematic in the surgical setting, where precise control over physiological parameters is paramount. One patient may experience significant sedation from a standard dose, while another exhibits minimal effects, despite similar demographics and medical history. Such variability complicates the management of anesthesia and increases the risk of adverse events. For example, a patient unexpectedly sensitive to the sedative effects of an antihistamine could experience prolonged respiratory depression during or after surgery, requiring more intensive monitoring and intervention. The inability to reliably predict individual responses undermines the precision required for safe and effective anesthesia management.
Further compounding the challenge is the potential for paradoxical reactions. While antihistamines are typically administered for their sedative or anti-allergic properties, some patients may experience the opposite effects, such as agitation, anxiety, or even hallucinations. These paradoxical reactions are particularly concerning in pediatric or elderly populations, where they can significantly complicate post-operative care and increase the risk of falls or self-harm. Additionally, the unpredictable nature of antihistamine effects extends to their interaction with other medications. The same antihistamine may potentiate the effects of certain anesthetics in one patient, while antagonizing them in another. This variability in drug interactions makes it difficult to anticipate and manage potential complications, such as hypotension, arrhythmias, or respiratory depression. Therefore, reliance on antihistamines pre-operatively introduces an element of uncertainty that compromises patient safety and necessitates careful consideration of alternative strategies.
In summary, the unpredictable nature of patient responses to antihistamines contributes significantly to the justification for avoiding their routine use before surgery. This unpredictability extends to both the intended effects of the medications and their interactions with other drugs, making it difficult to anticipate and manage potential complications. By minimizing the use of antihistamines, healthcare providers can reduce the uncertainty surrounding patient responses and improve the predictability and safety of surgical procedures. This necessitates a thorough pre-operative assessment, careful consideration of alternative therapies, and a commitment to evidence-based medication management practices that prioritize patient safety and minimize the risk of adverse events.
Frequently Asked Questions
The following addresses common inquiries regarding the avoidance of antihistamines before surgical procedures, providing evidence-based explanations to promote patient understanding and safety.
Question 1: Why is it generally advised to avoid antihistamines before surgery?
The avoidance stems from the potential for adverse interactions with anesthetic agents and other medications administered during surgery. Antihistamines can potentiate sedative effects, increasing the risk of respiratory depression and prolonged recovery. Furthermore, certain antihistamines can cause cardiovascular complications and cognitive impairment, complicating post-operative management.
Question 2: Are there specific antihistamines that pose a greater risk than others?
First-generation antihistamines, such as diphenhydramine and chlorpheniramine, are generally associated with a higher risk of sedation, anticholinergic effects, and drug interactions compared to second-generation antihistamines like loratadine or cetirizine. However, even second-generation antihistamines should be used with caution pre-operatively due to potential, albeit reduced, adverse effects.
Question 3: If an individual regularly takes antihistamines for allergies, should the medication be discontinued before surgery?
This decision requires careful consideration and consultation with the surgeon and anesthesiologist. Abruptly discontinuing antihistamines could lead to a rebound of allergic symptoms. In some cases, a less sedating alternative or a reduced dose may be appropriate. The optimal strategy depends on the individual’s specific allergy management plan and the nature of the surgical procedure.
Question 4: What are the potential cardiovascular risks associated with antihistamine use before surgery?
Certain antihistamines can prolong the QT interval on electrocardiograms, increasing the risk of potentially fatal ventricular arrhythmias, particularly in patients with pre-existing cardiac conditions. Additionally, some antihistamines can cause tachycardia and elevated blood pressure, which can be detrimental in patients with coronary artery disease or hypertension.
Question 5: Can pre-operative antihistamine use affect cognitive function after surgery?
Yes, antihistamines, especially those with anticholinergic properties, can contribute to post-operative cognitive impairment and delirium, particularly in elderly patients. This can manifest as confusion, disorientation, and difficulties with memory and attention, prolonging hospital stays and increasing the risk of complications.
Question 6: If an allergic reaction occurs during surgery, what alternative medications can be used?
In the event of an allergic reaction during surgery, anesthesiologists have a range of alternative medications and strategies available, including epinephrine, corticosteroids, and H2-receptor antagonists. These medications can effectively manage allergic reactions without the sedative and anticholinergic effects associated with pre-operative antihistamine use.
In summary, the decision to withhold antihistamines before surgery is based on evidence-based considerations of patient safety and the potential for adverse drug interactions. Individualized risk assessment and consultation with the surgical and anesthesia teams are essential to optimize perioperative care.
The next section will explore alternative strategies for managing allergic conditions in the perioperative setting.
Considerations Concerning Antihistamine Avoidance Before Surgery
The rationale for not administering antihistamines prior to surgical procedures warrants careful consideration. The subsequent guidelines are intended to enhance understanding and optimize patient safety.
Tip 1: Meticulous Medication Reconciliation: Thoroughly document and review all medications, including over-the-counter drugs and supplements, during the pre-operative assessment. This facilitates the identification of potential drug interactions with anesthetic agents.
Tip 2: Assessment of Allergic History: Obtain a comprehensive history of allergies, including specific allergens and previous reactions. This information is essential for developing an appropriate management plan and selecting alternative medications if necessary.
Tip 3: Anesthesia Consultation: Engage in detailed communication with the anesthesiology team. Discuss the patient’s medication history, allergies, and any concerns regarding potential drug interactions or adverse effects.
Tip 4: Alternative Medication Strategies: Explore alternative medications for managing allergic conditions or other indications for antihistamine use. Consider non-sedating antihistamines, corticosteroids, or other appropriate therapies.
Tip 5: Pre-Operative Education: Educate patients about the reasons for avoiding antihistamines before surgery and the potential risks associated with their use. Provide clear instructions on medication management and emphasize the importance of adhering to the pre-operative protocol.
Tip 6: Careful Monitoring: Implement vigilant monitoring during and after surgery to detect any adverse effects related to medication interactions or allergic reactions. This includes continuous monitoring of vital signs, respiratory function, and neurological status.
Tip 7: Individualized Risk Assessment: Conduct a thorough risk assessment for each patient, considering factors such as age, medical history, pre-existing conditions, and concurrent medications. Tailor the pre-operative medication plan to minimize the risk of adverse events and optimize patient outcomes.
Adherence to these guidelines promotes a safer surgical environment by minimizing drug interactions and optimizing patient physiological stability.
The concluding section summarizes the key findings regarding the avoidance of pre-operative antihistamine administration and emphasizes the importance of ongoing research in this area.
Conclusion
The preceding discussion has comprehensively explored the rationale behind “why no antihistamine before surgery.” It underscores that the risks associated with pre-operative antihistamine use, including potentiation of sedation, drug interactions, cardiovascular complications, and altered mental status, outweigh potential benefits in most scenarios. The emphasis on thorough medication reconciliation, individualized risk assessment, and communication with the anesthesia team is paramount to patient safety.
Given the complexities outlined, continued research is essential to refine pre-operative medication protocols and develop safer alternatives. A commitment to evidence-based practice and patient-centered care remains critical in minimizing surgical risks and optimizing patient outcomes. The decision to withhold antihistamines should not be viewed as a static guideline, but rather as a call to proactive and informed medical decision-making in the pursuit of optimal patient well-being during surgical procedures.
